Veneto-STOP study: Sequential assessment of minimal residual disease by next generation sequencing to optimize outcomes and minimize exposure in venetoclax-treated CLL patients Meeting Abstract
| Authors: | Ujjani, C. S.; Roeker, L. E.; Shadman, M.; Whitaker, K. J.; Jacob, A. P.; Geyer, M. B.; Dorsey, C.; Zelenetz, A. D.; Mato, A. R. |
| Abstract Title: | Veneto-STOP study: Sequential assessment of minimal residual disease by next generation sequencing to optimize outcomes and minimize exposure in venetoclax-treated CLL patients |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577160403030 |
| DOI: | 10.1182/blood-2019-124002 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1758 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work